Serum antibodies 9 years after cendehill rubella immunisation

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

ESMO open·2026

Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N = 7914).

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

ESMO open·2025

Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry.

ESMO open·2025

Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).

ESMO open·2025

Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

The Positive Impact of School Dental Prevention Programs: A Systematic Review and Meta-Analysis.

Health education & behavior : the official publication of the Society for Public Health Education·2026

Effectiveness of a Family-Centered Empowerment Model on Self-Efficacy in Patients with Hypertension: A Randomized Clinical Trial.

Iranian journal of nursing and midwifery research·2026

Strategies for strengthening eye care in India: a consensus-based recommendations.

The Lancet regional health. Southeast Asia·2026

Promoting physical activity and physical functioning among residents in nursing homes - lessons learnt by the PROGRESS project.

Frontiers in aging·2026

A Codesigned Approach to Develop Tailored Antimicrobial Stewardship Strategies in Bangladesh: A Social-Ecological Systems Framework Analysis.

Health expectations : an international journal of public participation in health care and health policy·2026

Awareness of Hepatitis C Test Results Among Reported Cases in Los Angeles County, 2021-2022.

Public health reports (Washington, D.C. : 1974)·2026

Related Experiment Videos

Serum antibodies 9 years after cendehill rubella immunisation

Related Concept Videos

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N = 7914).

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry.

Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).

Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

The Positive Impact of School Dental Prevention Programs: A Systematic Review and Meta-Analysis.

Effectiveness of a Family-Centered Empowerment Model on Self-Efficacy in Patients with Hypertension: A Randomized Clinical Trial.

Strategies for strengthening eye care in India: a consensus-based recommendations.

Promoting physical activity and physical functioning among residents in nursing homes - lessons learnt by the PROGRESS project.

A Codesigned Approach to Develop Tailored Antimicrobial Stewardship Strategies in Bangladesh: A Social-Ecological Systems Framework Analysis.

Awareness of Hepatitis C Test Results Among Reported Cases in Los Angeles County, 2021-2022.

Related Experiment Videos

Serum antibodies 9 years after cendehill rubella immunisation

Related Concept Videos

Related Articles